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ABSTRACT 
Background: Chronic kidney failure is a worldwide public health problem.Cardiovascular 
disease is a common complication and the main cause of mortality in this 
population.Impaired left atrial function is an early marker of cardiovascular involvement and 
a prognostic factor that correlated with mortality in chronic kidney disease patients. We aim 
to investigate the relationship between  P terminal force V1 (PTFV1), an ECG parameter, 
with left atrial function in chronic kidney failure patients on hemodialysis. 
Method: This cross sectional study was done in chronic kidney failure patients on 
hemodialysis in Dr. Sardjito General Hospital Jogjakarta. Electrocardiogram and 
echocardiography were done after hemodialysis procedure. P terminal force V1 was 
measured by multiplying amplitude and duration of negative deflection of terminal P wave in 
V1. Abnormal PTFV1 was defined as PTFV1 value ≥ 40 mm.msec. Left atrial function was 
measured using left atrial peak global longitudinal strain (LA PGLS). 
Results: This study was done in 71 patients with mean age 50 years old. Forty three 
subjects (61%) were men. Sixty four subjects (90%) had hypertension. Forty four subjects 
(62%) had abnormal PTFV1 on ECG. Mean LA PGLS was 24.89 ± 8.23%. No significant 
correlation was found between PTFV1 value with LA PGLS (r= -0.178; p=0.138). By 
multivariate analysis, left ventricular ejection fraction, left atrial diameter and hemodialysis 
duration (in months) were variables that independently correlated with LA PGLS. In 
subanalysis, amplitude of negative deflection of terminal P wave in V1 was significantly 
correlated with LA PGLS(r= -0.257, p= 0.031). 
Conclusions: This study reveals no correlation between P terminal force V1 and left atrial 
function in chronic kidney failure patients on routine hemodialysis. There is significant 
correlation between amplitude of negative deflection of terminal P wave in V1 with LA PGLS. 
Keywords: P Terminal Force V1; left atrial function; chronic kidney failure; hemodialysis 
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INTISARI 
Latar belakang: Gagal ginjal kronis menjadi masalah kesehatan masyarakat di seluruh 
dunia. Penyakit kardiovaskular merupakan komplikasi tersering dan penyebab utama 
kematian pada populasi ini. Gangguan fungsi atrium kiri menjadi penanda awal penyakit 
kardiovaskular dan merupakan faktor prognostik kematian pada pasien penyakit ginjal 
kronis. Kami bertujuan untuk menyelidiki hubungan antara P terminal force V1 (PTFV1), 
parameter EKG, dengan fungsi atrium kiri pada pasien gagal ginjal kronis yang menjalani 
hemodialisis. 
Metode: Penelitian cross sectional ini dilakukan pada pasien gagal ginjal kronis yang 
menjalani hemodialisis di RSUP Dr. Sardjito Jogjakarta. Elektrokardiogram dan 
ekokardiografi dilakukan setelah prosedur hemodialisis. P terminal force V1 diukur dengan 
mengalikan amplitudo dan durasi defleksi negatif dari gelombang terminal P di V1. P 
terminal force V1 abnormal didefinisikan sebagai nilai PTFV1 ≥40 mm.msec. Fungsi atrium 
kiri diukur menggunakan atrial peak global longitudinal strain (LA PGLS).  
Hasil: Penelitian ini dilakukan pada 71 pasien dengan usia rata-rata 50 tahun. Empat puluh 
tiga subjek (61%) adalah laki-laki. Enam puluh empat subjek (90%) memiliki hipertensi. 
Empat puluh empat subjek (62%) memiliki PTFV1 abnormal. Nilai rerata LA PGLS adalah 
24,89 ± 8,23%. Tidak ada korelasi signifikan yang ditemukan antara nilai PTFV1 dengan LA 
PGLS (r =-0,178; p =0,138). Pada analisis multivariat, fraksi ejeksi ventrikel kiri, diameter 
atrium kiri dan durasi hemodialisis (dalam beberapa bulan) merupakan variabel yang secara 
independen berkorelasi dengan LA PGLS. Dalam subanalisis, amplitudo defleksi negatif dari 
gelombang P terminal di V1 secara signifikan berkorelasi dengan LA PGLS (r =-0,257, p 
=0,031). 
Kesimpulan: Penelitian ini menunjukkan tidak ada korelasi antara kekuatan terminal P V1 
dan fungsi atrium kiri pada pasien gagal ginjal kronis yang menjalani hemodialisis rutin. 
Terdapat korelasi yang signifikan antara amplitudo defleksi negatif dari gelombang P 
terminal di V1 dengan LA PGLS. 
INTRODUCTION 
Chronic kidney disease (CKD) is a 
worldwide public health problem.1 The 
people with CKD have an increased 
cardiovascular risk.2 Cardiovascular 
disease (CVD) is the most common 
complication in this population and has 
becoming the most common cause of 
mortality in terminal kidney disease, 
constituting 45-50% of all cause mortality.3 
In terminal kidney disease patients, 
mortality from CVD reaches 10-20 times 
higher than healthy population.4 In this 
particular population, heart faces a chronic 
increased pressure and volume overload.5 
An impaired left atrial (LA) function 
that is measured by echocardiography (left 
atrial peak global longitudinal strain/LA 
PGLS)has emerged as an early marker of 
cardiovascular involvement and prognostic 
factor that is correlated with mortality in 
CKD patients.6-8 Echocardiography, 
especially with strain features, is scarce in 
rural areas. Meanwhile 
electrocardiography (ECG) is a cheap, 
easy to be used and available in rural 
districts.9 A P terminal force V1 is an ECG 
parameter that has been studied and 
known to be correlated not only with LA 
size but also LA pressure and function.10 
This aim of this study is to know the 
correlation between PTFV1 on ECG and 
LA function in CKD patients on 
hemodialysis. 
 
METHODS 
This study was a cross sectional 
study. The subjects were CKD patients on 
routine hemodialysis (minimum already on 
hemodialysis for 3 months) in Dr. Sardjito 
General Hospital. The inclusion criteria 
were:CKD patients on routine 
hemodialysis, 18-75 years old, willing to 
participate on this study and signing the 
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informed consent. Exclusion criteria were: 
patients with atrial fibrillation, patients with 
severe primary heart valve disease, 
patients whose echocardiographic pictures 
difficult to be analyzed (in obtaining LA 
strain values). From 175 subjects on 
routine hemodialysis in Dr. Sardjito 
Hospital, 79 subjects fulfilled inclusion 
criteria, 8 subjects were excluded (5 
subjects with atrial fibrillation and 3 
subjects’ echocardiographic pictures were 
unable to be analyzed). Finally there were 
71 subjects that participated in this study. 
 Electrocardiogram (ECG) and 
echocardiography were done within 24 
hours after hemodialysis procedure. A 
standard 12 leads ECG was done with ECG 
machine MAC 400 (General Electrics) and 
Cardisunny C110 (Fukuda M-E) with 
standard speed and callibration (25 
mm/second and 10 mm/milivolt). The result 
was then scanned and read using Image J 
software. A P terminal force V1 was 
measured by multiplying duration and 
amplitude of negative deflection of terminal 
P wave in lead V1. Abnormal PTFV1 was 
defined as PTFV1 value ≥ 40 mm.msec. 
Echocardiography was done with 
Vivid 7 and Cicid iq machine (General 
Electrics) by a trained echocardiographer. 
Standard echocardiography video was 
obtained, with particular attention to get 
good left atrium pictures (whole and not 
truncated) in apical four chamber and two 
chamber view. The video was then 
analyzed in work station with special 
software (Echo-Pac, General Electrics) to 
obtain LA PGLS with speckle tracking 
method. Peak value of left atrial global 
longitudinal strain curve at end systole 
(just before the mitral valve opening) was 
measured as LA PGLS. Normal value of 
LA PGLS is 39%.11 The consistency 
ofPTFV1 and LA PGLS measurement 
(interobserver variability) was asessed by 
Cohen’s kappa (K), if K >0.5 and p <0.05 
measurement result was considered 
similar. This study had ethical approval 
from Medical and Health Research Ethics 
Commitee (MHREC) Faculty of Medicine, 
Public Health and Nursing Universitas 
Gadjah Mada, Jogjakarta, Indonesia. 
Statistical analysis was done using 
SPSS software. Numerical data was 
presented as mean and standard 
deviation or median and minimum-
maximum value. Categorical data was 
presented as proportion. Baseline 
characteristics and confounding factors 
were analyzed using bivariate analysis. 
The variables with p < 0.25 in bivariate 
analysis, was then analyzed using 
multivariat analysis. Correlation between 
PTFV1 and LA PGLS was measured 
using Pearson or Spearman correlation 
analysis. P value <0.05 was considered 
statistically significant.  
 
RESULT 
Of the 71 subjects, 43 were male 
(61%) and the mean age was 49.94±12.58 
years (table 1). Mean systolic pressure 
was 138.85±25.19 mmHg, median 
diastolic pressure was 80 mmHg. Sixty 
four subjects (90.1%) had hypertension, 
16 subjects (22.9%) was smoker or had 
previous history of smoking, 23 subjects 
(32.4%) had diabetes mellitus and 15 
subjects (21.1%) had dyslipidemia. Forty 
four patients (62%) had abnormal PTFV1 
on ECG. Mean amplitude of negative 
deflection of terminal P wave in V1 was 
0.98±0.49 mm, mean duration of negative 
deflection of terminal P wave in V1 was 
50.95±16.43 miliseconds. Median PTFV1 
value was 44.16 (2.92-187.20) mm.ms. 
Thirty two subjects (45%) had 
abnormal LAVI (>28 mL/m2). Sixty two 
subjects (87%) had normal LVEF (> 50%). 
Fifty six subjects (71%) had abnormal 
LVMI. Sixty eight subjects (96%) had 
abnormal LA PGLS (table 1). 
Normality test using Kolmogorov-
Smirnov showed PTFV1 value data 
distribution was abnormal. Spearman 
analysis was used to analyse correlation 
between PTFV1 and LA PGLS. No 
correlation was found between PTFV1 and 
LA PGLS (r=-0.178; p=0.138). The scatter 
plot of this analysis is presented in figure 
1. 
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Table 1. Baseline characteristics  
 
PTFV1: P terminal force V1; ACE: angiotensin converting enzyme; ARB: angiotensin 
receptor blocker, LVIDd: left ventricular internal diastolic diameter; LVMI: left ventricular 
mass index;LA: left atrium; LAVI: left atrial volume index; PGLS: peak global longitudinal 
strain. 
ǂ data was presented as percentage 
†normal data distribution, data was presented as mean and standard deviation 
‡abnormal data distribution, data was presented as median, minimum and maximum value 
 
 
Variables Subjects (n=71) 
Genderǂ  
Male; n(%) 43 (61%) 
Female; n(%) 28 (39%) 
Age (years) † 49.94±12.58 
Traditional risk factorsǂ  
Hypertension; n(%) 64 (90%) 
Diabetes mellitus; n(%) 23 (32%) 
Dyslipidemia; n(%) 15 (21%) 
Smoking; n(%) 16 (23%) 
Heart rate (times per minute) † 81.7±14.28 
Systolic pressure (mmHg) † 138.85±25.19 
Diastolic pressure (mmHg) ‡ 80 (60-127) 
Body mass index (kg/m2) † 23.06±4.14 
Hemodialysis duration (months) ‡  36 (3-192) 
Medication useǂ 
      ACE inhibitor or ARB 60 (84%) 
Calcium channel blocker  57 (80%) 
Beta blocker  5 (7%) 
Abnormal PTFV1ǂ 44 (62%) 
Amplitude of negative deflection of terminal P wave in V1 (mm) † 0.98±0.49 
Duration of negative deflection of terminal P wave in V1 (ms) † 50.95±16.43 
PTFV1 value (mm.ms) ‡ 44.16 (2.92-187.20) 
LVIDd ‡ 48.00 (34.00-69.00) 
LVMI ‡ 144.61 (68.6-338.5) 
Abnormal LVMIǂ 56 (71%) 
Left ventricular ejection fraction (LVEF)‡ 69 (20.0-83.0) 
Normal LVEF(> 50%) 62 (87%) 
Left ventricular wall motionǂ  
      Normokinetic 59 (83%) 
      Wall motion abnormality 12 (17%) 
Left ventricular diastolic functionǂ  
      Normal 44 (62%) 
      Diastolic dysfunction 17 (24%) 
      Indeterminate 10 (14%) 
LA diameter† 38.03±5.78 
LAVI ‡ 27 (5.0-72.63) 
Abnormal LAVI (> 28 mL/m2) 32 (45%) 
LA PGLS† 24.89 ± 8.23  
Abnormal LA PGLS (< 39%)ǂ 68 (96%) 
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Figure 1.Scatter plot of PTFV1 value with LA PGLS in CKD undergoing hemodialysis population 
(r =-0.178; p =0.138). 
 
 
Table 2. Bivariate analysis of LA PGLS and confounding factors 
 
Confounding factors r p 
Age † -0.012 0.924 
Hemodialysis duration ‡ 0.181 0.130 
LA diameter † -0.481 0.000* 
LAVI ‡ -0.345 0.003* 
LVIDd ‡ -0.370 0.001* 
LVMI ‡ -0.289 0.015* 
LVEF ‡ 0.447 0.000* 
Amplitude of negative deflection of terminal P 
wave in lead V1 † 
-0.257 0.031* 
LVIDd: left ventricular internal diastolic diameter; LVMI: left 
ventricular mass index; LAVI: left atrial volume index; LA: left atrium; 
LVEF: left ventricular ejection fraction 
†normal data distribution, ‡abnormal data distribution,  
*data with significant value 
 
Further analysis was done for LA 
PGLS and the confounding factors. The 
confounding foctors are age, hemodialysis 
duration, LA diameter, LAVI, LVIDd, LVMI, 
LVEF, amplitude of negative deflection of 
terminal P wave in lead V1, diabetes 
mellitus, hypertension, LV diastolic 
dysfunction and medication usage (ACE 
inhibitor or ARB, CCB, beta blocker). 
Bivariate analysis between LA PGLS and 
the confounding factors is presented in 
table 2, meanwhile LA PGLS value mean 
difference among the confounding factors 
is presented in table 3.  
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Table 3. LA PGLS mean difference among the confounding factors 
 
Confounding factors Yes No p 
Diabetes mellitus 
22.23±5.94 
(n=23) 
26.16±8.89 
(n=48) 
0.058 
Hypertension 
25.14±8.50  
(n= 64) 
22.61±4.89  
(n= 7) 
0.444 
Diastolic dysfunction 
18.41±6.44  
(n= 17) 
27.76±7.95  
(n= 44) 
0.000* 
ACE inhibitor/ARB 
24.27±7.83 
(n=60) 
28.27±9.83 
(n=11) 
0.139 
CCB 
24.97±7.78 
(n=57) 
24.54±10.15 
(n=14) 
0.862 
Beta blocker 
22.33±10.02  
(n= 5) 
28.27±9.83  
(n= 11) 
0.475 
ACE: angiotensin converting enzyme; ARB: angiotensin 
receptor blocker; CCB: calcium channel blocker 
* data with significant value 
 
 
Table 4. Multivariate analysis of LA PGLS and the confounding factors 
 
Confounding factors r P 
LVEF 0.450 0.005* 
LA diameter -0.325 0.030* 
Hemodialysis duration 0.247 0.037* 
LVIDd 0.197 0.277 
ACE inhibitor / ARB -0.114 0.326 
Diabetes mellitus 0.107 0.337 
LVMI  -0.064 0.650 
LV diastolic disfunction -0.056 0.634 
LAVI -0.012 0.938 
Amplitude of negative deflection of terminal 
P wave in lead V1 
-0.058 0.597 
LVIDd:left ventricular internal diastolic diameter; LVMI: left ventricular mass 
index;LAVI: left atrial volume index; LA: left atrium; LVEF: left ventricular 
ejection fraction; ACE: angiotensin converting enzyme; ARB: angiotensin 
receptor blocker 
*data with significant value 
 
Confounding factors with p <0.25 
was then included in multivariate analysis. 
Based on the multivariate analysis, LVEF, 
LA diameter and hemodialysis duration 
were independently associated with LA 
PGLS (table 4). 
Furthermore, a subanalysis was 
doneto see the correlation between 
PTFV1 components (duration and 
amplitude of negative deflection of 
terminal P wave in lead V1) with LA 
PGLS. Components of PTFV1 had normal 
data distribution (analyzed using 
Kolmogorov-Smirnov), correlation analysis 
was done using Pearson analysis. 
Correlation analysis between 
duration of negative deflection of terminal 
P wave in lead V1 and LA PGLS using 
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Pearson showed a negative correlation 
with r =-0.112, but this association is not 
significant (p =0.351). Meanwhile 
correlation analysis between amplitude of 
negative deflection of terminal P wave in 
lead V1 and LA PGLS using Pearson 
showed a significant negative correlation 
with r  =-0.257 (p = 0.031). The result is 
presented in table 5 and the scatter plot is 
showed in figure 2. In linear regression 
test it was found that each 1 mm increase 
in the depth of  negative deflection of 
terminal P wave in lead V1 will decrease 
LA PGLS value of 4.34% (p =0.031).
 
 
Table 5.Correlation of P terminal force V1 components with LA PGLS 
 
P Terminal Force V1 components r p 
Amplitude of negative deflection of terminal P wave in V1 
(mm)  
-0.257 0.031* 
Durationof negative deflection of terminal P wave in V1 
(milidetik) 
-0.112 0.351 
LA PGLS: left atrial peak global longitudinal strain  
*data with significant value 
 
 
Figure2. Scatter plotdepicting correlation between amplitude of negative deflection of terminal P wave 
in V1 and LA PGLS (r = -0.257, p <0.05). 
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DISCUSSION 
Abnormal PTFV1 was found in 44 
subjects (62%) out of total 71 subjects in 
this study. This is consistent with previous 
finding, that abnormal PTFV1 was found in 
66% patients on routine hemodialysis.10 
Prevalence of abnormal PTFV1 in 
hemodialysis population is higher than in 
normal population (7,5%).12 This is 
because there is increased LA size in 
terminal kidney disease population that’s 
happened because pressure and volume 
overload and high prevalence of LV 
diastolic dysfunction in this population.13,14 
Mean LA PGLS in this study is 
24.89±8.23%, lower than normal value 
from meta analisis by Pathan et al. (39%). 
This is consistent with previous findings in 
CKD patients that showed decreased LA 
PGLS value i.e 25.7±9.3% dan 
28.8±14,.9%.15,16 These showed that there 
is impaired LA function in CKD patients, 
this can be caused by an increased 
pressure and volume overload in this 
population that finally cause LA 
remodelling.14,17 
In this study, PTFV1 value is not 
correlated with LA PGLS. This is different 
with previous study that showed significant 
correlation between PTFV1 and LA 
function in hemodialysis patients.11 The 
difference might be caused by different 
hemodialysis characteristics related with 
fluid overload, i.e in previous study, 
hemodialysis was done three times a 
week and in this study hemodialysis was 
done twice a week. This can influence 
body’s volume status. When LA is 
overloaded, P wave vector will rotate to 
the left and posterior, causing prominent 
negative component of P wave in V1.18 
From multivariate analysis it is 
found that LA diameter, LVEF and 
hemodialysis duration are factors that 
independently associated with LA PGLS. 
Left atrial PGLS resembles LA reservoir 
function.19 From previous study, it is found 
that LA reservoir function consists of early 
and late phase. Early reservoir function 
depends on LA relaxation meanwhile late 
reservoir function depends on LV 
contraction (descent of LV base) at 
systole.20 This can explain why LVEF 
independently associated with LA PGLS. 
An LA dilatation is the hallmark of 
LA structural remodelling. Increased 
pressure or volume overload can increase 
LA size, but pressure overload usually 
accompanied by abnormal myocyte 
relaxation, meanwhile in volume overload, 
myocyte relaxation usually normal.21 In 
CKD, LA not only face increased volume 
overload but also pressure overload 
(because of hypertension and LV diastolic 
dysfunction).14 Impaired atrial relaxation 
surely will impair LA reservoir function 
measured by LA PGLS. 
Hemodialysis duration is 
associated independently with LA PGLS (r 
= 0,247; p = 0,037). Hemodialysis itself 
can cause ischemia, injury and impaired 
myocardial function because non 
physiologic fluid removal and decreased 
intradialytic myocardial perfusion.22 
Repeated interdialytic fluid retention also 
contributed to LV hyperthrophy, LV 
diastolic dysfunction and finally LA 
remodelling.14,23 But as the patients getting 
used to hemodialysis, they were exposed 
to essential information such as the 
importance of fluid control and routine 
consumption of medication. Discipline fluid 
restriction will produce optimal interdialytic 
weight gain so that cardiac load can be 
controlled well.24 Good colume control and 
antiremodelling medication can help 
reverse remodelling to happen and this 
can repair LA size and function.17,25 
Duration of negative deflection of 
terminal P wave in V1 is not associated 
with LA PGLS (r = -0.112, p = 0.351), but 
amplitude of of negative deflection of 
terminal P wave in V1 significantly 
associated with LA PGLS (r= -0.257, p = 
0.031). This is consistent with previous 
findings that there is no correlation 
between duration of negative deflection of 
terminal P wave in V1 and LA PGLS, 
meanwhile amplitude of negative 
deflection of terminal P wave in V1 was 
correlated significantly with LA strain, i.e 
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for each increase 0,1 mV in the depth of 
negative deflection of terminal P wave in 
V1 is associated with LA strain decrease 
7,5% (p = 0.037).18 
Duration of negative deflection of 
terminal P wave in V1 represents 
time/duration of impulse conduction in LA. 
This represents impaired conduction in 
atrium or LA dilatation so that impuls need 
more time to finish the conduction in the 
whole LA.18,26 Meanwhile amplitude of 
negative deflection of terminal P wave in 
V1 represents LA wall hyperthrophy. 
Loewe et al. with an in silico LA model 
found that LA wall thickness was strongly 
correlated with amplitude of of negative 
deflection of terminal P wave in V1, but P 
wave duration was almost not influenced 
by LA wall thickness.27 This anatomical 
changes (LA wall hyperthrophy) can 
influence myocyte relaxation function.17,21 
The impaired function is caused by 
functional remodelling that cause 
contractile protein isoform composition 
changes that finally cause impaired 
relaxation of myocytes.28,29 
 
Limitations 
This research did not study LA 
conduit and contractile strain. Parameter 
in hemodialysis i.e ultrafiltration rate and 
volume was not taken and analyzed in this 
research.  
 
CONCLUSIONS 
This study reveals no correlation 
between P terminal force V1 and left atrial 
function measured with left atrial peak 
global longitudinal strain in chronic kidney 
failure patients on routine hemodialysis. 
There is significant correlation between 
amplitude of negative deflection of 
terminal P wave in V1 with LA PGLS. 
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